Morgan Stanley Issues Positive Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH) had its target price boosted by Morgan Stanley from $375.00 to $395.00 in a research report released on Wednesday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the healthcare conglomerate’s stock.

UNH has been the subject of a number of other research reports. Evercore raised UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target for the company in a research report on Tuesday, April 7th. Weiss Ratings cut UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, March 2nd. Truist Financial reaffirmed a “buy” rating and issued a $395.00 price target (up from $370.00) on shares of UnitedHealth Group in a research report on Wednesday. Finally, Leerink Partners boosted their price target on UnitedHealth Group from $345.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $377.68.

UnitedHealth Group Price Performance

UNH opened at $353.51 on Wednesday. The stock has a fifty day moving average price of $290.76 and a 200 day moving average price of $317.09. UnitedHealth Group has a 1 year low of $234.60 and a 1 year high of $438.85. The stock has a market cap of $320.88 billion, a price-to-earnings ratio of 26.70, a PEG ratio of 1.53 and a beta of 0.40. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. During the same quarter in the prior year, the business posted $7.20 EPS. UnitedHealth Group’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Analysts forecast that UnitedHealth Group will post 18.43 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

Hedge Funds Weigh In On UnitedHealth Group

Several large investors have recently made changes to their positions in UNH. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Anfield Capital Management LLC raised its holdings in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $27,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and raised guidance — UNH reported Q1 adjusted EPS of $7.23 (vs. consensus ~$6.76) and revenue of ~$111.7B, and raised FY‑2026 adjusted EPS guidance to above $18.25, citing improved management of medical costs. This is the main catalyst for the rally. Business Wire — Q1 Results
• Positive Sentiment: Analyst upgrades and price‑target increases — Multiple firms (Argus, RBC, Oppenheimer, Wells Fargo, Morgan Stanley, Jefferies, etc.) raised ratings or targets after the report, adding upward pressure as sell‑side momentum attracts buyers. 247wallst — Analyst Upgrades
• Positive Sentiment: AI & operational initiatives — Management flagged a meaningful AI investment (and Optum Real transaction scale), which investors view as a durable margin/efficiency tailwind if deployment scales as planned. That narrative supports higher multiple assumptions. Yahoo Finance — Q1 Deep Dive (AI)
• Positive Sentiment: Bullish options flow — Unusual activity: ~164k call options traded (≈30% above average), signaling short‑term bullish positioning from traders and institutional players.
• Neutral Sentiment: Sector sentiment spillover — UNH’s beat dragged peers higher (CVS, Humana, Centene); positive industry momentum can amplify the stock move but doesn’t change UNH’s fundamentals. Yahoo — Sector Impact
• Negative Sentiment: Ongoing risks remain — Management warned of challenges around a Medicare obesity‑drug pilot and cautioned that medical‑cost dynamics are still the key risk; if costs reaccelerate, margins and guidance could reverse. Reuters — Medicare Obesity Drug Pilot Challenges

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.